Interleukin-6 bedside testing in women at high risk of preterm birth

J Matern Fetal Neonatal Med. 2011 Oct;24(10):1301-4. doi: 10.3109/14767058.2011.558954. Epub 2011 Mar 7.

Abstract

Objective: Infection is likely to contribute to preterm birth (PTB). Laboratory analysis has demonstrated that vaginal IL-6 is correlated with PTB. We aimed to investigate a bedside test in this context.

Method: Vaginal secretions were collected from 71 asymptomatic high-risk women. After 20 minutes incubation at room temperature, samples were analyzed by the bedside reader (IL-6 concentration in pg/ml) (Milenia-Biotec, Germany). Maternal and neonatal infectious markers and pregnancy outcome were recorded.

Results: IL-6 was related to PTB, latency to gestation and maternal infection but not neonatal infection. In women with visible fetal membranes (n = 13), all of those with a high IL-6 (≥56 pg/ml) had a PTB (n = 11) compared to half (n = 1) with a low IL-6 (<56 pg/ml). All the women with a high IL-6 at <24 weeks' (n = 10) delivered before viability compared to none with a low IL-6 (n = 2). In women with preterm prelabor rupture of membrane (PPROM) and high IL-6 (n = 8) there was a trend toward more extreme PTB's (57% vs. 0%, p = 0.19) and delivery within 7 days (71% vs. 50%, p = 0.09) compared to low IL-6 (n = 5).

Conclusion: IL-6 may be useful in guiding the difficult management of patients with visible membranes and PPROM, for example, the potential benefit of a cervical cerclage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Gestational Age
  • Humans
  • Interleukin-6 / analysis*
  • Point-of-Care Systems*
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis*
  • Premature Birth / etiology*
  • Vagina / metabolism*

Substances

  • IL6 protein, human
  • Interleukin-6